Study 8 of 18 for search of: Open Studies | "Hair Diseases"
Previous Study Return to Search Results Next Study

Full Text View
Tabular View
Contacts and Locations
No Study Results Posted
Related Studies
Enhanced Safety Aesthetic Laser System
This study is not yet open for participant recruitment.
Verified by Scilex Ltd., July 2007
Sponsored by: Scilex Ltd.
Information provided by: Scilex Ltd.
ClinicalTrials.gov Identifier: NCT00495443
  Purpose

The purpose of this study is to determine whether a new laser system provides better safety and efficacy than existing lasers in popular cosmetic procedures such as hair removal, treatment of cosmetically disturbing vascular lesions and rhytides.


Condition Intervention
Hirsutism
Hypertrichosis
Telangiectases
Rhytides
Device: Peterio

U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Single Blind, Historical Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Peterio™ – an Add-on Device for Enhanced Safety of Aesthetic Laser Treatments

Further study details as provided by Scilex Ltd.:

Primary Outcome Measures:
  • Hair, vascular lesions and wrinkles reduction as counted 1-3 months after each treatment session, depending on the treated area.

Secondary Outcome Measures:
  • Measuring treatment discomfort as graded by the patients

Estimated Enrollment: 25
Study Start Date: September 2007
Estimated Study Completion Date: September 2008
Detailed Description:

Cosmetic lasers are a well-established, popular modality for removal of unwanted hair, treatment of all types of vascular lesions, including hemangiomas, port wine stains, and a variety of telangiectases as well as facial rhytides reduction. The existing lasers are based on a wavelength that is specifically absorbed by the chromophore found in the target such as hair follicle, where the energy is converted to heat resulting in a thermal injury. However, the lasers for cosmetic treatments are not without limitations. A laser based long-term hair removal treatment is based on thermal destruction of the hair shaft and follicle using wavelengths that are specifically absorbed by the pigment melanin found in the hair follicle. The heating of hair follicle is done through heat dissipation from the hair shaft. One of the significant limitations of this approach is the fact that the epidermis through which the light energy must penetrate is rich in melanin and therefore absorbs a major portion of the energy, resulting in inadequate heating of the hair follicles. Similar problem exists when targeting other chromophores such as hemoglobin or water. The purpose of the study is an evaluation of safety and efficacy of a new laser based device.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age between 18 and 75 years old
  • Fitzpatrick skin types I to VI
  • Unwanted hair or/and
  • Aesthetically disturbing vascular lesions or/and
  • Facial rhytides

Exclusion Criteria:

  • Age below 18 or above 75 year old.
  • Use of photosensitive medications
  • Photosensitive diseases
  • Active infection of any type and active infection or or a history of Herpes Simplex in the treated site
  • Exposure to sun or artificial tanning during the last 3–4 weeks
  • For treatment of facial rhytides- surgical or nonsurgical facial procedure (i.e., laser skin resurfacing, dermabrasion, phenol peel, nonablative laser, or temporary/permanent filler (e.g., collagen, fat, hyaluronic acid injections)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00495443

Contacts
Contact: Alex Rapoport, BSC 972-39506949 alecr@netvision.net.il

Locations
Israel
Hadassah Medical Center, Dermatology
Jerusalem, Israel, 91120
Sponsors and Collaborators
Scilex Ltd.
Investigators
Principal Investigator: Leon Gilad, MD Hadassah Medical Center, Dermatology
  More Information

Publications:
Study ID Numbers: Peterio-06
Study First Received: July 1, 2007
Last Updated: July 1, 2007
ClinicalTrials.gov Identifier: NCT00495443  
Health Authority: Israel: Ministry of Health

Study placed in the following topic categories:
Signs and Symptoms
Hirsutism
Skin Diseases
Telangiectasis
Vascular Diseases
Hypertrichosis

Additional relevant MeSH terms:
Hair Diseases
Cardiovascular Diseases
Virilism

ClinicalTrials.gov processed this record on February 12, 2009